✦ LIBER ✦

Clinical implications of the mechanism of epidermal growth factor receptor inhibitors

✍ Scribed by John Marshall

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 189 KB
Volume: 107
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.22133

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Novel therapeutic agents that target the epidermal growth factor receptor (EGFR) constitute an important addition to the therapeutic armamentarium for the treatment of metastatic disease. EGFR‐targeted agents currently approved by the U.S. Food and Drug Administration include cetuximab, a monoclonal antibody for the treatment of colorectal cancer; and the small‐molecule EGFR tyrosine kinase inhibitor (TKI) erlotinib for the treatment of nonsmall cell lung cancer (NSCLC) and pancreatic cancer. Approval of the TKI gefitinib for NSCLC recently was withdrawn. Although both classes of anti‐EGFR agents target the same receptor, substantial distinctions regarding their mechanism significantly affect dosing requirements, toxicity profiles, and their use as combination agents. Cancer 2006. © 2006 American Cancer Society.

📜 SIMILAR VOLUMES

Salicylanilides as Inhibitors of the Pro

Salicylanilides as Inhibitors of the Protein Tyrosine Kinase Epidermal Growth Factor Receptor.

✍ Christoph Liechti; Urs Sequin; Guido Bold; Pascal Furet; Thomas Meyer; Peter Tra 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 100 KB 👁 2 views

## Abstract For Abstract see ChemInform Abstract in Full Text.

Design and Synthesis of Novel Epidermal

Design and Synthesis of Novel Epidermal Growth Factor Receptor Kinase Inhibitors.

✍ Jae Du Ha; Seung Kyu Kang; Kun-Do Kim; Joong-Kwon Choi; Jae Yang Kong; Chang H. 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 10 KB 👁 2 views

Transforming growth factor-alpha short-c

Transforming growth factor-alpha short-circuits downregulation of the epidermal growth factor receptor

✍ Xiaomei Ouyang; Timothy Gulliford; Guocai Huang; Richard J. Epstein 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

Transforming growth factor-alpha (TGF␣) is an epidermal growth factor receptor (EGFR) ligand which is distinguished from EGF by its acid-labile structure and potent transforming function. We recently reported that TGF␣ induces less efficient EGFR heterodimerization and downregulation than does EGF (

Contributions of the epidermal growth fa

Contributions of the epidermal growth factor receptor to keratinocyte motility

✍ Hudson, Laurie G.; McCawley, Lisa J. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB 👁 2 views

The epidermal growth factor (EGF) receptor plays a central role in numerous aspects of keratinocyte biology. In normal epidermis, the EGF receptor is important for autocrine growth of this renewing tissue, suppression of terminal differentiation, promotion of cell survival, and regulation of cell mi

Effects of epidermal growth factor recep

Effects of epidermal growth factor receptor inhibitor-induced dermatologic toxicities on quality of life

✍ Smita S. Joshi; Sara Ortiz; Joslyn N. Witherspoon; Alfred Rademaker; Dennis P. W 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

1,4-Dioxane-fused 4-anilinoquinazoline a

1,4-Dioxane-fused 4-anilinoquinazoline as inhibitors of epidermal growth factor receptor kinase

✍ Jae Yeol Lee; Yong Kyu Park; Seon Hee Seo; In-Seop So; Hee-Kyung Chung; Beom-Seo 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB 👁 2 views